Université de Montréal
Founded in 1878, the University of Montreal is the largest university in Quebec and the second largest in Canada, with over 64,000 students, including nearly 8,000 from around the world, and with more than 11,000 diplomas awarded at every university level each year. Deeply rooted in Montreal and dedicated to its international mission, the University of Montreal is one of the top universities in the French-speaking world and is ranked 29th on the list of top international institutions in Pharmacy and pharmacology by the QS World University Rankings.
Groupe de recherche universitaire sur le médicament (GRUM)
The University Drug Research Group (GRUM) brings together researchers interested in all aspects of drug R&D at the Université de Montréal. The mission of GRUM is to support training, transdisciplinary research and technology transfer relating to drug discovery, development and evaluation.
Fondation Toulouse Cancer Santé
Fondation Toulouse Cancer Santé is a research foundation created by 5 worldwide private companies (Amgen – GSK – Pierre Fabre – Siemens – Total) involved in research and innovation, which has been state-approved May 5th 2006, with a special endowment of ANR, the French agency for research. The aim of the Foundation is to define, promote and finance cooperative actions to develop research and industry in the life sciences and especially in oncology by supporting the highly innovative areas that are: Nano & Bio & Information Technologies and also Radiotherapy and Imaging techniques (“NBI Tech 2 Life”). Based on the Oncopole, in Toulouse, which is a campus, unique in Europe, that brings together on a single site public and private research, academic organizations, industry including pharmaceutical leaders and SMEs, medical and clinical expertise. These actors are committed to working together to achieve a single goal: more effectively fight cancer. By co-organizing the Summer School on Medicines since the first edition, Fondation Toulouse Cancer Santé shows its involvement in multidisciplinary education dedicated to students in life sciences and health, but also in technological sciences.
University of Barcelona
The University of Barcelona (UB) is the top public institution of higher education in Catalonia, catering to the needs of the greatest number of students and delivering the broadest and most comprehensive offering in higher educational courses. The UB is also the principal center of university research in Spain and has become a European benchmark for research activity, both in terms of the number of research programs it conducts and the excellence these have achieved.
The UB occupies a competitive position at national, European and worldwide levels in the most important ranking tables designed on a range of variables within different geographical areas. The UB holds a place among the top 250 world universities, according to the new edition of the ranking edited by the British journal The Times Higher Education(THE), and improves its leading position in the QS World University Rankings 2018 thereby becoming the first one in Spain, holding the 156th position worldwide and the 64th in Europe.
The UB is member of the most important international excellence university networks, such as the League of European Research Universities (LERU). It has overseen the creation of two campuses of international excellence: the Barcelona Knowledge Campus (BKC) and the Health University of Barcelona Campus (HUBc). The Barcelona Knowledge Campus (BKC), a project presented jointly by the UB and the Technical University of Catalonia (UPC), merges the two universities’ training, research and innovation potential on Barcelona. The project officially known as the Health Universitat de Barcelona Campus (HUBc) is dedicated to training, research and knowledge transfer, and it brings together two faculties, two university schools and six hospitals all working in various fields of health science.
Institute of Biomedicine of the University of Barcelona
The Institute of Biomedicine of the University of Barcelona (IBUB)(www.ub.edu/ibub) is a transversal research unit that brings together 40 groups from the Faculties of Biology, Pharmacy and Food Sciences and Chemistry. The IBUB was born in 2006 with the aim of identifying, beyond the classical academic structures (departments and faculties), a set of laboratories with complementary scientific activity, capable of generating synergies.
Although the name of the institute is generalist, its research activity is focused on drug and target discovery. The IBUB strategic plan 2018-2021 encompasses a variety of actions for the promotion of a research profile oriented towards the discovery of new biological targets and drugs susceptible to become novel generation drugs. For this purpose, there are, in addition to strong biological foundations -well endorsed by groups with extensive experience in cell and animal models suitable for molecular screening, highly recognized groups in the field of computational design of new drugs and top level laboratories in organic synthesis. These capabilities are structured in two areas, the Integrative Biology Program and the Drug Discovery Program. The ultimate objective of the Institute is to ensure that intramural synergies are translated into an increase in the scale of value of their discoveries, thus providing added value to all those who are likely to be transferred to the industrial sector.
Biocat is the organization that champions the healthcare and life sciences ecosystem in Catalonia working to transform science and technology into regional economic growth as well as social impact.
Ribeirão Preto Medical School, University of São Paulo
Faculdade de Medicina de Ribeirão Preto (Ribeirão Preto Medical School in Portuguese) is a medical school of the University of São Paulo (USP) located in the city of Ribeirão Preto, state of São Paulo, Brazil, founded 1952. It is considered one of the three best medical schools in the country and a premier medical research center.
Mission: “Providing excellence in higher education, providing training of health professionals with a high level of qualification and potential of leadership, based on ethical, moral, scientific and humanistic principles; training qualified researchers in its graduate programs and produce high-quality innovative research with international insertion, exploring the boundaries of knowledge, but also attentive to the society needs; continuing interaction with the public sector and with the society in order to promote qualified assistance in health and in the dissemination of new knowledge.”
Universidade de São Paulo
The University of São Paulo (USP) is a public University in the Brazilian state of São Paulo founded in 1934. It is the largest Brazilian public University and the country’s most prestigious educational institution, being recently ranked 51-60 worldwide in reputation by the Times Higher Education World University Rankings. USP is one of the largest institutions of higher education in Latin America, with approximately 95,000 enrolled students. Currently, it has eleven campuses, four of them in the city of São Paulo, two in São Carlos, and the remaining campuses in the cities of Bauru, Lorena, Piracicaba, Pirassununga, and Ribeirão Preto. USP is involved in teaching, research, and extension activities in all areas of knowledge. In terms of research, USP is Brazil’s largest research institution, producing more than 25% of the scientific papers published by Brazilian researchers in high quality conferences and journals- Providing innovative training and developing talent, by designing and executing programs and initiatives to improve talent and entrepreneurship considered essential factors for the growth of the sector.
Montreal Clinical Research Institute
Founded in 1967, the Montreal Clinical Research Institute (IRCM) is a non-profit organization that conducts basic and clinical biomedical research in addition to training high-level scientists in an innovative technological environment. With approximately 425 people, the Institute brings together more than 35 laboratories working in the fields of cancer, immunology, neuroscience, cardiovascular and metabolic diseases, systems biology and medicinal chemistry. The IRCM also runs research clinics specializing in hypertension, nutrition and diabetes as well as a Research Centre on Rare and Genetic Diseases in Adults. The IRCM is affiliated with Université de Montréal and associated with McGill University.
Institute for Research in Immunology and Cancer — Commercialization of Research
The Institute for Research in Immunology and Cancer — Commercialization of Research (IRICoR) is a not-for-profit drug discovery and commercialization centre based at the Institute for Research in Immunology and Cancer (IRIC) of the Université de Montréal (UdeM). In 2008, the shared vision of IRIC’s scientists and the UdeM administration led to the creation of IRICoR. The Center was awarded an initial funding of $15M by the Government of Canada as a Centre of Excellence for Commercialization and Research (CECR). IRICoR’s main objective is to rapidly translate highly innovative scientific projects from IRIC, UdeM and collaborating centres into high value novel therapies in oncology, immunology and related indications through strong partnerships with the private sector — thereby efficiently bridging the innovation translation gap between early stage academic research and industry.